Emeacr (Europe, Middle East & Africa Clinical Research)

Europe, Middle East & Africa/Asia Clinical Research (EMEACR) is a Full Service CRO providing clinical trial services to the pharma, medical device and biotech companies in Europe, USA and Emerging Markets. EMEACR is headquartered in Dubai, UAE with an operational office in Belgium, headed by a management team with extensive experience within the clinical research environment. We are able to cover Worldwide studies from Phase 1-4 and also BEBA studies. Our mission at EMEACR, as leading CRO in Emerging Markets regions, we believe in developing clinical trials in Emerging Market region in addition to Europe, because it means better treatments and better access for patients in that region as well. We want to contribute in improving patients’ life, by helping and encouraging the pharmaceutical/biotech and medical device companies to develop their novel life saving drugs in the Emerging Markets. With EMEACR, Drug Discovery companies finally found a reliable CRO partner with which they can perform their clinical trials in those Emerging Markets in Africa, Middle East and Asia in addition to Europe. We can put in place an organization, thanks to our LOCAL and REGIONAL EXPERTISE, ensuring that patients remain the central point and that the study timelines are met. EMEACR was built with the spirit of being a reliable service provider. It means that our role is not only limited to execution, but we also advise and guide our clients on the best way to conduct their studies in those Emerging Markets, taking into account the local specificities. Our vision is to become the reference CRO specialized in conducting clinical research in Europe and Emerging Markets, offering state of the art quality services, and cost effective solutions. We strive to employ people with genuine expertise in the region and with a passion for excellence. We offer a dynamic and stimulating working environment; with good opportunities for career development in a growing, innovative company.